Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
50 /100
MEDIUM RISK
Score updated Oct 13, 2026

EBS — Emergent BioSolutions Inc. Dilution Risk Tracker

Track EBS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track EBS — Get alerts when the score changes →

As of October 13, 2026, Emergent BioSolutions Inc. (EBS) has a DilutionWatch DilutionScore of 50/100, rated MEDIUM dilution risk. Emergent BioSolutions Inc. has a market capitalization of $357.89M, 51.27M shares outstanding, 192 institutional holders tracked. Stored dilution-related fields include 2.50M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
85
📊 Float Risk
15
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 17%
💰 Capital Raise model 35%
• Low cash runway: 6 months remaining
🔔 Track EBS — Get forecast alerts →

Market Data

Market Cap$357.89M
Shares Outstanding51.27M
Float49.38M
Cash$139.70M
Debt$581.80M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore50/100DilutionWatch score record
Shares Outstanding51.27MVerified float table or market cache
Public Float49.38MVerified float table or market cache
Market Cap$357.89MMarket data cache
Cash Runway5.7 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants2.50MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 4, 8-K 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 11.9% shares (2026Q1 vs prior)
192 institutional holders · 49.68M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 4.52M shares
#2 BlackRock, Inc. 4.34M shares
#3 STATE STREET CORP 2.85M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest9.29M
Days to Cover8.3
% of Float18.8%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-06
xbrl XBRL CONVERTIBLE 2021-02-19
8-K 8K EVENT 2026-04-17
4 INSIDER TRANSACTION 2026-04-03
4 INSIDER TRANSACTION 2026-03-06
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual EBS Dilution Snapshot

Emergent BioSolutions Inc. (EBS) has a DilutionScore of 50/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

EBS's DilutionScore is currently 50/100 (Medium risk), with 2 score changes tracked over 89 days. The score improved from 44/100 (Medium risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202650/100MEDIUM53 days
Aug 14 – Aug 21, 202644/100MEDIUM7 days
Jul 16 – Aug 13, 202647/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

EBS shares outstanding have decreased 0.3% from 51.77M (Mar 2026) to 51.60M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 31, 202651.60M49.38M▼ 1.08%
May 30, 202651.60M49.92M▼ 1.22%
May 29, 202651.60M50.53M▼ 0.06%
May 18, 202651.60M50.56M▲ 7.70%
May 09, 202651.60M46.95M▼ 0.04%
May 06, 202651.60M46.97M▼ 0.39%
May 04, 202651.80M47.15M▲ 0.03%
May 02, 202651.80M47.14M▲ 0.06%
Apr 13, 202651.64M47.11M▲ 0.63%
Mar 26, 202651.77M46.81M▼ 0.03%
Mar 21, 202651.77M46.83M▼ 0.02%
Mar 09, 202651.77M46.84M▲ 0.20%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track EBS Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment EBS files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking EBS — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for EBS
EBS FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.